Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 04, 2022

SELL
$351.38 - $448.68 $271,616 - $346,829
-773 Closed
0 $0
Q3 2021

Oct 18, 2021

BUY
$372.64 - $458.3 $15,278 - $18,790
41 Added 5.6%
773 $319,000
Q2 2021

Jul 30, 2021

BUY
$294.17 - $371.65 $215,332 - $272,047
732 New
732 $271,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Heartland Bank & Trust CO Portfolio

Follow Heartland Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Bank & Trust CO with notifications on news.